Technical Analysis for MNTA - Momenta Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade B 13.58 3.66% 0.48
MNTA closed up 3.66 percent on Friday, October 11, 2019, on 66 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical MNTA trend table...

Date Alert Name Type % Chg
Crossed Above 20 DMA Bullish 0.00%
Gapped Up Strength 0.00%
200 DMA Support Bullish 6.80%
50 DMA Support Bullish 6.80%
Golden Cross Bullish 6.80%
NR7 Range Contraction 2.80%
Up 3 Days in a Row Strength 2.80%
Stochastic Buy Signal Bullish 3.59%
Oversold Stochastic Weakness 3.59%
50 DMA Support Bullish 5.93%

Older signals for MNTA ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Momenta Pharmaceuticals, Inc., a biotechnology company, engages in the structural characterization, process engineering, and biologic systems analysis of complex molecules. Its complex molecules include polysaccharides, polypeptides, and proteins and antibodies. The company's complex generics programs comprise Enoxaparin sodium injection, a generic version of Lovenox that is used for the prevention and treatment of deep vein thrombosis, and to support the treatment of acute coronary syndromes; and M356, a generic version of Copaxone, which is a glatiramer acetate injection indicated for the reduction of the frequency of relapses in patients with relapsing-remitting multiple sclerosis. Its biosimilars programs include M923, a biosimilar for autoimmune and inflammatory diseases; M834 for autoimmune and inflammatory diseases; and M511, a monoclonal antibody for oncology. The company's novel products comprise M402, a novel heparan sulfate mimetic that binds to various growth factors, adhesion molecules, and chemokines to inhibit tumor angiogenesis, progression, and metastasis; and the sialylation technology, which is a discovery program that is intended to modify immunoglobulin G antibodies in intravenous immunoglobulin, a drug to treat autoimmune and inflammatory diseases. It has collaboration agreements with Sandoz AG; Baxter International, Inc.; Baxter Healthcare Corporation; and Baxter Healthcare SA. The company was formerly known as Mimeon, Inc. and changed its name to Momenta Pharmaceuticals, Inc. in September 2002. Momenta Pharmaceuticals, Inc. was founded in 2001 and is headquartered in Cambridge, Massachusetts.
Medicine Biotechnology Immunology Antibodies Immune System Tumor Antibody Autoimmunity Monoclonal Antibody Autoimmune And Inflammatory Diseases Glycoproteins Metastasis Biosimilar Deep Vein Thrombosis Relapsing Remitting Multiple Sclerosis Acute Coronary Syndromes Immunoglobulin Therapy
Is MNTA a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 16.48
52 Week Low 9.51
Average Volume 458,225
200-Day Moving Average 12.6858
50-Day Moving Average 12.7442
20-Day Moving Average 13.2615
10-Day Moving Average 12.9325
Average True Range 0.5823
ADX 14.81
+DI 27.7541
-DI 19.9392
Chandelier Exit (Long, 3 ATRs ) 12.7331
Chandelier Exit (Short, 3 ATRs ) 13.9569
Upper Bollinger Band 14.1501
Lower Bollinger Band 12.3729
Percent B (%b) 0.68
BandWidth 13.401199
MACD Line 0.0604
MACD Signal Line 0.0992
MACD Histogram -0.0388
Fundamentals Value
Market Cap 1 Billion
Num Shares 73.8 Million
EPS -0.64
Price-to-Earnings (P/E) Ratio -21.22
Price-to-Sales 9.20
Price-to-Book 2.70
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 14.42
Resistance 3 (R3) 14.39 14.09 14.28
Resistance 2 (R2) 14.09 13.87 14.10 14.23
Resistance 1 (R1) 13.83 13.74 13.96 13.86 14.19
Pivot Point 13.53 13.53 13.59 13.54 13.53
Support 1 (S1) 13.27 13.31 13.40 13.30 12.97
Support 2 (S2) 12.97 13.18 12.98 12.93
Support 3 (S3) 12.71 12.97 12.88
Support 4 (S4) 12.74